Bellevue Total Stockholder Equity vs Deferred Long Term Liab Analysis
| BLAC Stock | 11.30 0.04 0.36% |
Bellevue Life financial indicator trend analysis is way more than just evaluating Bellevue Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bellevue Life Sciences is a good investment. Please check the relationship between Bellevue Life Total Stockholder Equity and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bellevue Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Total Stockholder Equity vs Deferred Long Term Liab
Total Stockholder Equity vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bellevue Life Sciences Total Stockholder Equity account and Deferred Long Term Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Bellevue Life's Total Stockholder Equity and Deferred Long Term Liab is 0.59. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Bellevue Life Sciences, assuming nothing else is changed. The correlation between historical values of Bellevue Life's Total Stockholder Equity and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Bellevue Life Sciences are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Total Stockholder Equity i.e., Bellevue Life's Total Stockholder Equity and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | 0.59 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Bellevue Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bellevue Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bellevue Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Bellevue Life's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 65.61, whereas Tax Provision is forecasted to decline to about 297.4 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 3.3K | 35.4K | 1.8M | 1.9M | Depreciation And Amortization | 236.6K | 228.5K | 2.8M | 2.9M |
Bellevue Life fundamental ratios Correlations
Click cells to compare fundamentals
Bellevue Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bellevue Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.